Seagen is a global biotechnology company dedicated to revolutionising cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives.
As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering safe and effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumours and blood-related cancers.
Seagen U.K. Ltd.
The Charter Building
Charter Place
Uxbridge UB8 1LG
UK
Email: OfficeUK@seagen.com
For medical information contact
(+44) 330 818 0490
medinfoEU@seagen.com
Companies House Registry 06321958 - VAT GB355368868
Job Code EUM/COR/2023/0006